Literature DB >> 27392715

Peripheral vascular function, oxygen delivery and utilization: the impact of oxidative stress in aging and heart failure with reduced ejection fraction.

D Walter Wray1,2,3, Markus Amann1,2,3, Russell S Richardson4,5,6.   

Abstract

The aging process appears to be a precursor to many age-related diseases, perhaps the most impactful of which is cardiovascular disease (CVD). Heart disease, a manifestation of CVD, is the leading cause of death in the USA, and heart failure (HF), a syndrome that develops as a consequence of heart disease, now affects almost six million American. Importantly, as this is an age-related disease, this number is likely to grow along with the ever-increasing elderly population. Hallmarks of the aging process and HF patients with a reduced ejection fraction (HFrEF) include exercise intolerance, premature fatigue, and limited oxygen delivery and utilization, perhaps as a consequence of diminished peripheral vascular function. Free radicals and oxidative stress have been implicated in this peripheral vascular dysfunction, as a redox imbalance may directly impact the function of the vascular endothelium. This review aims to bring together studies that have examined the impact of oxidative stress on peripheral vascular function and oxygen delivery and utilization with both healthy aging and HFrEF.

Entities:  

Keywords:  Blood flow; Cardiovascular disease; Endothelial function; Free radicals; O2; Oxygen transport

Mesh:

Substances:

Year:  2017        PMID: 27392715      PMCID: PMC5219949          DOI: 10.1007/s10741-016-9573-4

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  120 in total

Review 1.  Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part III: cellular and molecular clues to heart and arterial aging.

Authors:  Edward G Lakatta
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

2.  Nitric oxide and passive limb movement: a new approach to assess vascular function.

Authors:  Joel D Trinity; H Jonathan Groot; Gwenael Layec; Matthew J Rossman; Stephen J Ives; Sean Runnels; Ben Gmelch; Amber Bledsoe; Russell S Richardson
Journal:  J Physiol       Date:  2012-02-06       Impact factor: 5.182

3.  Limited maximal exercise capacity in patients with chronic heart failure: partitioning the contributors.

Authors:  Fabio Esposito; Odile Mathieu-Costello; Ralph Shabetai; Peter D Wagner; Russell S Richardson
Journal:  J Am Coll Cardiol       Date:  2010-05-04       Impact factor: 24.094

4.  Oral antioxidants improve leg blood flow during exercise in patients with chronic obstructive pulmonary disease.

Authors:  Matthew J Rossman; Joel D Trinity; Ryan S Garten; Stephen J Ives; Jamie D Conklin; Zachary Barrett-O'Keefe; Melissa A H Witman; Amber D Bledsoe; David E Morgan; Sean Runnels; Van R Reese; Jia Zhao; Markus Amann; D Walter Wray; Russell S Richardson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-07-17       Impact factor: 4.733

5.  K+ balance of the quadriceps muscle during dynamic exercise with and without beta-adrenoceptor blockade.

Authors:  L Gullestad; J Hallén; O M Sejersted
Journal:  J Appl Physiol (1985)       Date:  1995-02

6.  Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis.

Authors:  D S Celermajer; K E Sorensen; V M Gooch; D J Spiegelhalter; O I Miller; I D Sullivan; J K Lloyd; J E Deanfield
Journal:  Lancet       Date:  1992-11-07       Impact factor: 79.321

7.  The reaction of no with superoxide.

Authors:  R E Huie; S Padmaja
Journal:  Free Radic Res Commun       Date:  1993

8.  A differing role of oxidative stress in the regulation of central and peripheral hemodynamics during exercise in heart failure.

Authors:  Melissa A H Witman; John McDaniel; Anette S Fjeldstad; Stephen J Ives; Jia Zhao; Jose N Nativi; Josef Stehlik; D Walter Wray; Russell S Richardson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-09-07       Impact factor: 4.733

Review 9.  Convective oxygen transport and fatigue.

Authors:  Markus Amann; Jose A L Calbet
Journal:  J Appl Physiol (1985)       Date:  2007-10-25

10.  The Mechanoreflex and Hemodynamic Response to Passive Leg Movement in Heart Failure.

Authors:  Stephen J Ives; Markus Amann; Massimo Venturelli; Melissa A H Witman; H Jonathan Groot; D Walter Wray; David E Morgan; Josef Stehlik; Russell S Richardson
Journal:  Med Sci Sports Exerc       Date:  2016-03       Impact factor: 5.411

View more
  14 in total

1.  Impacts of prolonged sitting with mild hypercapnia on vascular and autonomic function in healthy recreationally active adults.

Authors:  Ronald J Headid; Elizabeth J Pekas; TeSean K Wooden; Won-Mok Son; Gwenael Layec; John Shin; Song-Young Park
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-07-10       Impact factor: 4.733

2.  Chronic antioxidant administration restores macrovascular function in patients with heart failure with reduced ejection fraction.

Authors:  Kanokwan Bunsawat; Stephen M Ratchford; Jeremy K Alpenglow; Soung Hun Park; Catherine L Jarrett; Josef Stehlik; Stavros G Drakos; Russell S Richardson; D Walter Wray
Journal:  Exp Physiol       Date:  2020-06-18       Impact factor: 2.969

3.  Is Willebrand Factor Indicative of Chronic Inflammation in Children with Asthma?

Authors:  Nataliia Makieieva; Valeriia Malakhova; Yuliia Vasylchenko; Maryna Biriukova
Journal:  Turk Thorac J       Date:  2020-11-01

4.  Dietary Nitrate Increases VO2peak and Performance but Does Not Alter Ventilation or Efficiency in Patients With Heart Failure With Reduced Ejection Fraction.

Authors:  Andrew R Coggan; Seth R Broadstreet; Kiran Mahmood; Deana Mikhalkova; Michael Madigan; Indra Bole; Soo Park; Joshua L Leibowitz; Ana Kadkhodayan; Deepak P Thomas; Dakkota Thies; Linda R Peterson
Journal:  J Card Fail       Date:  2017-09-12       Impact factor: 5.712

5.  Locomotor Muscle Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction.

Authors:  Michael A Francisco; Joshua F Lee; Zachary Barrett-O'Keefe; H Jonathan Groot; Stephen M Ratchford; Kanokwan Bunsawat; Jeremy K Alpenglow; John J Ryan; Jose N Nativi; Russell S Richardson; D Walter Wray
Journal:  Hypertension       Date:  2021-11-01       Impact factor: 10.190

6.  Sacubitril/valsartan protects against arsenic trioxide induced cardiotoxicity in vivo and in vitro.

Authors:  Zhiqiang Wu; Hongzhu Chen; Liwang Lin; Jing Lu; Qilei Zhao; Zengxiang Dong; Xin Hai
Journal:  Toxicol Res (Camb)       Date:  2022-05-16       Impact factor: 2.680

7.  Contrast Ultrasound Assessment of Skeletal Muscle Recruitable Perfusion after Permanent Left Ventricular Assist Device Implantation: Implications for Functional Recovery.

Authors:  Divya Soman; James Hodovan; Conrad J Macon; Brian P Davidson; J Todd Belcik; James O Mudd; Byung S Park; Jonathan R Lindner
Journal:  J Am Soc Echocardiogr       Date:  2021-12-29       Impact factor: 7.722

Review 8.  Redox theory of aging: implications for health and disease.

Authors:  Young-Mi Go; Dean P Jones
Journal:  Clin Sci (Lond)       Date:  2017-06-30       Impact factor: 6.124

9.  Advanced Maternal Age Worsens Postpartum Vascular Function.

Authors:  Jude S Morton; Alison S Care; Raven Kirschenman; Christy-Lynn Cooke; Sandra T Davidge
Journal:  Front Physiol       Date:  2017-06-30       Impact factor: 4.566

10.  Sacubitril-valsartan improves conduit vessel function and functional capacity and reduces inflammation in heart failure with reduced ejection fraction.

Authors:  Kanokwan Bunsawat; Stephen M Ratchford; Jeremy K Alpenglow; Soung Hun Park; Catherine L Jarrett; Josef Stehlik; Adam S Smith; Russell S Richardson; D Walter Wray
Journal:  J Appl Physiol (1985)       Date:  2020-11-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.